4DMedical Limited
FDMDF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $74,374 | $201,309 | $237,587 | $341,253 |
| - Cash | $6,879 | $30,606 | $69,576 | $51,115 |
| + Debt | $4,308 | $5,121 | $5,139 | $6,239 |
| Enterprise Value | $71,803 | $175,824 | $173,149 | $296,377 |
| Revenue | $5,853 | $3,050 | $719 | $1,054 |
| % Growth | 91.9% | 324.4% | -31.8% | – |
| Gross Profit | $5,389 | $2,813 | -$24,278 | $281 |
| % Margin | 92.1% | 92.2% | -3,378.6% | 26.6% |
| EBITDA | -$46,047 | -$31,857 | -$43,832 | -$35,255 |
| % Margin | -786.7% | -1,044.6% | -6,099.9% | -3,343.9% |
| Net Income | -$30,070 | -$35,979 | -$31,460 | -$24,593 |
| % Margin | -513.7% | -1,179.8% | -4,378% | -2,332.6% |
| EPS Diluted | -0.14 | -0.097 | -0.1 | -0.084 |
| % Growth | -44.2% | 2.9% | -19.8% | – |
| Operating Cash Flow | -$34,475 | -$30,867 | -$22,653 | -$25,269 |
| Capital Expenditures | -$86 | -$303 | -$1,614 | -$3,078 |
| Free Cash Flow | -$34,561 | -$31,170 | -$24,266 | -$28,347 |